In summary, breast cancer patients with the SULT1A1 rs9282861 homozygous variant AA genotype and treated with either adjuvant TAM or chemotherapy had statistically significantly better OS compared with the carriers of other rs9282861 genotypes. Here, SULT1A1 is linked to breast cancer.